Literature DB >> 181681

Catecholamine receptor agonists: effects on motor activity and rate of tyrosine hydroxylation in mouse brain.

U Strömbom.   

Abstract

Motor activity during the first 5 min in a motility meter was measured in mice given 0.025-3.2 mg/kg of the dopamine and noradrenaline receptor agonists apomorphine and clonidine, respectively. The accumulation of Dopa, as induced by the inhibitor of aromatic amino acid decarboxylase, NSD 1015, was measured in parallel in two dopamine-rich regions, i.e. the limbic system and the corpus striatum, and in two noradrenaline-rich regions, i.e. the neocortex and the lower brain stem. Low doses (0.025-0.2 mg/kg) of apomorphine reduced locomotion in a dose-dependent manner, while the reduction after higher doses was less pronounced, indicating a biphasic dose-response relationship. Clonidine caused a dose-dependent locomotor depression. When low doses of the two drugs were combined, the inhibitory effect observed was at least additive. When clonidine was combined with a high dose of apomorphine (0.8 mg/kg), it caused a significant inhibition of locomotion in a dose of 0.1-0.2 mg/kg, but not after 0.8 mg/kg, indicating a biphasic dose-response relationship. Either drug given alone reduced Dopa accumulation after inhibition of its decarboxylation, in all regions, but smaller doses of apomorphine had a clearcut effect only in the dopamine-rich regions, whereas the lowest dose of clonidine investigated (0.05 mg/kg) had an inhibitory effect on Dopa formation only in the neocortex. The relationship between the dose of apomorphine and Dopa formation in the neocortex appeared biphasic, the highest dose (3.2 mg/kg) having no significant effect. Further, apomorphine in this dose accelerated the disappearance of noradrenaline after inhibition of synthesis by alpha-methyltyrosine. Reversal of reserpine-induced suppression of motor activity was taken to indicate postsynaptic receptor activation. The threshold dose of apomorphine causing reversal was 0.2 mg/kg. The inhibitory effect of e.g. 0.05 mg/kg on locomotion and on Dopa formation suggests a preferential activation of inhibitory autoregulatory dopamine receptors by low doses of this drug. A similar trend was observed for clonidine. The basal importance of dopamine neurones for the locomotor function studied in the present paper is illustrated by the marked inhibition by low doses of apomorphine. On the other hand, the observations with clonidine suggest a somewhat less striking and perhaps less direct influence of noradrenaline neurones on motor activity. Mice with a low motor activity, as induced e.g. by reserpine or, in another experiment, mice adapted to the motility meter, displayed an increased motor activity after higher doses of apomorphine (from 0.2 and 2 mg/kg, respectively), whereas all doses depressed the initial high motor activity. Probably, high motor activity requires active dopamine neurones, making this behaviour more susceptible to interference with autoregulatory mechanisms, whereas a low basal activity may be more affected by activation of postsynaptic dopamine receptors.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 181681     DOI: 10.1007/bf00498588

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  26 in total

1.  A fluorometric method for the estimation of tyrosine in plasma and tissues.

Authors:  T P WAALKES; S UDENFRIEND
Journal:  J Lab Clin Med       Date:  1957-11

2.  Simultaneous measurement of tyrosine and tryptophan hydroxylase activities in brain in vivo using an inhibitor of the aromatic amino acid decarboxylase.

Authors:  A Carlsson; J N Davis; W Kehr; M Lindqvist; C V Atack
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1972       Impact factor: 3.000

3.  A comparison of effects of apomorphine and ET495 on locomotor activity and circling behaviour in mice.

Authors:  J E Thornburg; K E Moore
Journal:  Neuropharmacology       Date:  1974-03       Impact factor: 5.250

Review 4.  Mode of action of psychomotor stimulant drugs.

Authors:  J M Van Rossum
Journal:  Int Rev Neurobiol       Date:  1970       Impact factor: 3.230

Review 5.  Determinants of the specificity of behavioral effects of drugs.

Authors:  R T Kelleher; W H Morse
Journal:  Ergeb Physiol       Date:  1968

6.  Dopamine and noradrenaline receptor stimulation: reversal of reserpine-induced suppression of motor activity.

Authors:  N E Andén; U Strömbom; T H Svensson
Journal:  Psychopharmacologia       Date:  1973

7.  The determination of dopamine by a modification of the dihydroxyindole fluorimetric assay.

Authors:  C V Atack
Journal:  Br J Pharmacol       Date:  1973-08       Impact factor: 8.739

8.  Effect of ethanol on the hydroxylation of tyrosine and tryptophan in rat brain in vivo.

Authors:  A Carlsson; M Lindqvist
Journal:  J Pharm Pharmacol       Date:  1973-06       Impact factor: 3.765

Review 9.  Dopamine (3-hydroxytyramine) and brain function.

Authors:  O Hornykiewicz
Journal:  Pharmacol Rev       Date:  1966-06       Impact factor: 25.468

10.  Effects of phenoxybenzamine, aceperone and clonidine on the level of 3-methoxy-4-hydroxyphenylglycol (MOPEG) in rat brain.

Authors:  C Braestrup
Journal:  J Pharm Pharmacol       Date:  1974-02       Impact factor: 3.765

View more
  66 in total

1.  Effects of locally applied dopamine to the nucleus accumbens on the motor activity of normal rats and following alpha-methyltyrosine or reserpine.

Authors:  H Wachtel; S Ahlenius; N E Andén
Journal:  Psychopharmacology (Berl)       Date:  1979-06-21       Impact factor: 4.530

2.  On the selectivity and specificity of the antagonism of apomorphine-induced suppression of exploration by sulpiride.

Authors:  L Ståhle; U Ungerstedt
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

3.  Discontinuation of chronic clonidine treatment: evidence for facilitated brain noradrenergic neurotransmission.

Authors:  T H Svensson; U Strömbom
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-08       Impact factor: 3.000

4.  Behavioural and biochemical effects of chronic reduction of cerebral noradrenaline receptor stimulation.

Authors:  A Dolphin; M Christina; M C Sawaya; P Jenner; C D Marsden
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-09       Impact factor: 3.000

5.  Chronic neuroleptics alter the effects of the D1 agonist SK&F 38393 and the D2 agonist LY171555 on oral movements in rats.

Authors:  G Ellison; P Johansson; E Levin; R See; L Gunne
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

6.  Partial protection against hyperbaric oxygen induced convulsions by dopaminergic agents in mice: possible involvement of autoreceptors?

Authors:  C O Criborn; C Henriksson; S Ahlenius; V Hillegaart
Journal:  J Neural Transm       Date:  1987       Impact factor: 3.575

7.  Clonidine-induced sedation in rats: evidence for mediation by postsynaptic alpha 2-adrenoreceptors.

Authors:  C Spyraki; H C Fibiger
Journal:  J Neural Transm       Date:  1982       Impact factor: 3.575

8.  Behavioral responses to apomorphine and amphetamine in differentially housed mice.

Authors:  C A Wilmot; C Vander Wende; M T Spoerlein
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

9.  Effects of the local application of 3-PPP and sulpiride enantiomers into the nucleus accumbens or into the ventral tegmental area on rat locomotor activity: evidence for the functional importance of somatodendritic autoreceptors.

Authors:  S Ahlenius
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-05       Impact factor: 3.000

10.  Course of depressive mood and psychomotor activation in endogenous depression.

Authors:  F Strian; W Albert; C Klicpera
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1979
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.